Forensic intelligence for medicine anti-counterfeiting

被引:40
作者
Degardin, Klara [1 ]
Roggo, Yves [1 ]
Margot, Pierre [2 ]
机构
[1] F Hoffmann La Roche & Co Ltd, CH-4303 Wurmisweg, Kaiseraugst, Switzerland
[2] Univ Lausanne, Inst Forens Sci, Sch Criminal Sci, CH-1015 Lausanne, Switzerland
关键词
Counterfeit medicines; Profiling; Packaging; Chemical composition; Seizure information; Operational decision-making; RAMAN-SPECTROSCOPY; MASS-SPECTROMETRY; IDENTIFICATION; DRUGS; SIBUTRAMINE; TABLETS;
D O I
10.1016/j.forsciint.2014.11.015
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Medicine counterfeiting is a crime that has increased in recent years and now involves the whole world. Health and economic repercussions have led pharmaceutical industries and agencies to develop many measures to protect genuine medicines and differentiate them from counterfeits. Detecting counterfeit is chemically relatively simple for the specialists, but much more information can be gained from the analyses in a forensic intelligence perspective. Analytical data can feed criminal investigation and law enforcement by detecting and understanding the criminal phenomenon. Profiling seizures using chemical and packaging data constitutes a strong way to detect organised production and industrialised forms of criminality, and is the focus of this paper. Thirty-three seizures of a commonly counterfeited type of capsule have been studied. The results of the packaging and chemical analyses were gathered within an organised database. Strong linkage was found between the seizures at the different production steps, indicating the presence of a main counterfeit network dominating the market. The interpretation of the links with circumstantial data provided information about the production and the distribution of counterfeits coming from this network. This forensic intelligence perspective has the potential to be generalised to other types of products. This may be the only reliable approach to help the understanding of the organised crime phenomenon behind counterfeiting and to enable efficient strategic and operational decision making in an attempt to dismantle counterfeit network. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:15 / 32
页数:18
相关论文
共 54 条
[1]   Growing threat from counterfeit medicines [J].
不详 .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2010, 88 (04) :247-248
[2]  
[Anonymous], 2009, KEEPING IT REAL COMB
[3]  
[Anonymous], 2008, Environmental Outlook to 2030, P1, DOI DOI 10.1787/TEACHSAL-TABLE-2013-1-EN
[4]   Why and How to Make an International Crime of Medicine Counterfeiting [J].
Attaran, Amir ;
Bate, Roger ;
Kendall, Megan .
JOURNAL OF INTERNATIONAL CRIMINAL JUSTICE, 2011, 9 (02) :325-354
[5]   A counterfeit drug treaty: great idea, wrong implementation [J].
Bate, Roger ;
Attaran, Amir .
LANCET, 2010, 376 (9751) :1446-1448
[6]  
Bate R, 2009, AFR J PHARM PHARMACO, V3, P165
[7]   Profiling of counterfeit medicines by vibrational spectroscopy [J].
Been, Frederic ;
Roggo, Yves ;
Degardin, Klara ;
Esseiva, Pierre ;
Margot, Pierre .
FORENSIC SCIENCE INTERNATIONAL, 2011, 211 (1-3) :83-100
[8]  
Degardin K., 2010, SPECTRA ANAL, V276, P46
[9]  
Degardin K., 2013, COUNTERFEIT MED, VII, P1
[10]  
Degardin K., 2011, Eur. Pharmaceutic. Rev., V2011, P22